CD8A and neoplasm: Furthermore, the percentage of CD3+CD8+ T cells obviously increased to 46.7% in tumor tissues after CPIP@EV–CM + US treatment, which was approximately 2.1-fold greater than the PBS group (21.9%) (Fig. 6k, Supplementary Fig. 30b).